(Q36374793)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Riociguat for pulmonary arterial hypertension associated with congenital heart disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

main subject

congenital disorder

0 references

arterial hypertension

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Stephan Rosenkranz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Maurice Beghetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Dunbar Ivy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Reiner Frey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Arno Fritsch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Gerrit Weimann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Soundos Saleh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Christian Apitz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

English

0 references

publication date

1 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

1792-1799

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2).

18 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Pediatric pulmonary hypertension.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Soluble guanylate cyclase stimulators in pulmonary hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

The chemistry and biology of soluble guanylate cyclase stimulators and activators

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Riociguat for the treatment of pulmonary arterial hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Pulmonary arterial hypertension associated with congenital heart disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Mechanisms of disease: pulmonary arterial hypertension.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Changing demographics of pulmonary arterial hypertension in congenital heart disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Identification of treatment goals in paediatric pulmonary arterial hypertension.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Updated Clinical Classification of Pulmonary Hypertension

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Frequency and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Guidelines for the diagnosis and treatment of pulmonary hypertension.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4680166

Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification

21 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26135803

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26135803

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/HEARTJNL-2015-307832

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

PubMed publication ID

26135803

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26135803%20AND%20SRC:MED&resulttype=core&format=json